CALSADA CRISPINA 4
4 · Regulus Therapeutics Inc. · Filed Jan 18, 2024
Insider Transaction Report
Form 4
CALSADA CRISPINA
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-18$1.19/sh−5,468$6,510→ 5,782 total
Footnotes (1)
- [F1]Sale of shares of common stock to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 1/11/2023.